Related references
Note: Only part of the references are listed.Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion
Nick Hornigold et al.
BRITISH JOURNAL OF CANCER (2020)
Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma
Alexander Cox et al.
ANTICANCER RESEARCH (2020)
High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy
Debebe Theodros et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Kidney Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase
Eleonora Orlando et al.
CANCER LETTERS (2019)
C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
Paulina Marona et al.
CELLS (2019)
Targeting Tyrosine kinases in Renal Cell Carcinoma: New Bullets against Old Guys
Teresa Alonso-Gordoa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers
Wei Zhu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression
Minsun Jung et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
David J. Clark et al.
CELL (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Genenames.org: the HGNC and VGNC resources in 2019
Bryony Braschi et al.
NUCLEIC ACIDS RESEARCH (2019)
Korean Alcohol Guidelines for Moderate Drinking Based on Facial Flushing
Sami Lee et al.
KOREAN JOURNAL OF FAMILY MEDICINE (2019)
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
Yongchang Lai et al.
CANCER CELL INTERNATIONAL (2018)
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
Toni K. Choueiri et al.
EUROPEAN JOURNAL OF CANCER (2018)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
Peter Makhov et al.
MOLECULAR CANCER THERAPEUTICS (2018)
The multiple paths towards MET receptor addiction in cancer
Leslie Duplaquet et al.
ONCOGENE (2018)
Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers
Chung-Ting Jimmy Kou et al.
BIOMED RESEARCH INTERNATIONAL (2018)
The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma
C. Hermanns et al.
ONCOGENE (2017)
Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer
Karim Fahmy et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma
G. T. Gibney et al.
ANNALS OF ONCOLOGY (2013)
Targeting the Hepatocyte Growth Factor/c-Met Signaling Pathway in Renal Cell Carcinoma
Lauren C. Harshman et al.
CANCER JOURNAL (2013)
Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer
Andrei Turtoi et al.
CANCER RESEARCH (2013)
c-MET Regulates Myoblast Motility and Myocyte Fusion during Adult Skeletal Muscle Regeneration
Micah T. Webster et al.
PLOS ONE (2013)
Tyrosine kinase expression profile in clear cell renal cell carcinoma
Turang E. Behbahani et al.
WORLD JOURNAL OF UROLOGY (2012)
Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo
Carol Yu et al.
VASCULAR PHARMACOLOGY (2011)
Myoferlin is required for insulin-like growth factor response and muscle growth
Alexis R. Demonbreun et al.
FASEB JOURNAL (2010)
MET signalling: principles and functions in development, organ regeneration and cancer
Livio Trusolino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
Jing Chen et al.
NUCLEIC ACIDS RESEARCH (2009)
Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function
Pascal N. Bernatchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma
Yasuyoshi Miyata et al.
CLINICAL CANCER RESEARCH (2006)
The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas
N Ahmad et al.
HUMAN PATHOLOGY (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
